Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.
Journal: Acta haematologica
Published: December 16, 2024
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 08, 2017
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 02, 2017
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Journal: Breast cancer research and treatment
Published: September 23, 2015
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
Journal: British journal of haematology
Published: June 22, 2015
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 04, 2015
Amrubicin as second- or third-line treatment for women with metastatic HER2-negative breast cancer: a Sarah Cannon Research Institute phase 1/2 trial.
Journal: Breast cancer research and treatment
Published: August 13, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026